Success rate of dental implants in HIV patients: an overview of systematic reviews

AIMS: To identify whether individuals with positive serology for HIV have a higher risk of losing the dental implant for this treatment. METHODS AND RESULTS: This study was conducted according to PRISMA guidelines and registered in the international prospective registry of systematic reviews, PROSPERO. The databases consulted were MEDLINE via PubMed, Scopus, DARE Cochrane, LILACS, Base, and Google Scholar. The search descriptors: “HIV,” “dental implants” and “AIDS” were used. To assess methodological quality, the AMSTAR 2 tool was used, and the entire process was reviewed in pairs, in addition, a third evaluator was consulted in case of disagreement. Four systematic reviews were included, encompassing 1239 implants in 450 patients with positive serology for HIV. Success rate of the dental implants was 94.72%, with a standard deviation of 0.455%. Three were classified as critically low-quality and one as moderate-quality. CONCLUSION: Similar implant survival rates were observed in HIV-negative patients. Therefore, the disease itself does not appear to have a significant influence on osseointegration. New controlled studies with low bias and high methodological quality are needed to ensure rehabilitation with dental implants with greater predictability and safety for HIV individuals

• Population(s)
  • General HIV+ population
• Co-morbidities
  • Other